Nextensa (Belgium) Performance
| NEXTA Stock | 37.80 0.05 0.13% |
The company secures a Beta (Market Risk) of -0.17, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Nextensa are expected to decrease at a much lower rate. During the bear market, Nextensa is likely to outperform the market. At this point, Nextensa NV has a negative expected return of -0.15%. Please make sure to verify Nextensa's potential upside, daily balance of power, as well as the relationship between the Daily Balance Of Power and market facilitation index , to decide if Nextensa NV performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Nextensa NV has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's fundamental drivers remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors. ...more
| Begin Period Cash Flow | 2.7 M | |
| Total Cashflows From Investing Activities | -5.9 M |
Nextensa |
Nextensa Relative Risk vs. Return Landscape
If you would invest 4,170 in Nextensa NV on December 21, 2024 and sell it today you would lose (390.00) from holding Nextensa NV or give up 9.35% of portfolio value over 90 days. Nextensa NV is generating negative expected returns and assumes 1.4407% volatility on return distribution over the 90 days horizon. Simply put, 12% of stocks are less volatile than Nextensa, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Nextensa Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nextensa's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Nextensa NV, and traders can use it to determine the average amount a Nextensa's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1027
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NEXTA |
Estimated Market Risk
| 1.44 actual daily | 12 88% of assets are more volatile |
Expected Return
| -0.15 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Nextensa is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nextensa by adding Nextensa to a well-diversified portfolio.
Nextensa Fundamentals Growth
Nextensa Stock prices reflect investors' perceptions of the future prospects and financial health of Nextensa, and Nextensa fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Nextensa Stock performance.
| Return On Equity | 0.0869 | |||
| Return On Asset | 0.0299 | |||
| Profit Margin | 0.43 % | |||
| Operating Margin | 0.56 % | |||
| Current Valuation | 1.27 B | |||
| Shares Outstanding | 9.94 M | |||
| Price To Book | 0.58 X | |||
| Price To Sales | 3.68 X | |||
| Revenue | 94.8 M | |||
| EBITDA | 75.13 M | |||
| Total Debt | 554.2 M | |||
| Book Value Per Share | 79.27 X | |||
| Cash Flow From Operations | 86.53 M | |||
| Earnings Per Share | 5.21 X | |||
| Total Asset | 1.9 B | |||
About Nextensa Performance
By analyzing Nextensa's fundamental ratios, stakeholders can gain valuable insights into Nextensa's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Nextensa has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Nextensa has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about Nextensa NV performance evaluation
Checking the ongoing alerts about Nextensa for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Nextensa NV help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Nextensa NV generated a negative expected return over the last 90 days | |
| About 71.0% of the company shares are owned by institutional investors |
- Analyzing Nextensa's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Nextensa's stock is overvalued or undervalued compared to its peers.
- Examining Nextensa's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Nextensa's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Nextensa's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Nextensa's stock. These opinions can provide insight into Nextensa's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Nextensa Stock analysis
When running Nextensa's price analysis, check to measure Nextensa's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nextensa is operating at the current time. Most of Nextensa's value examination focuses on studying past and present price action to predict the probability of Nextensa's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nextensa's price. Additionally, you may evaluate how the addition of Nextensa to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Global Correlations Find global opportunities by holding instruments from different markets |